Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

NCT00697216 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: HBV-MPL vaccine 208129
BIOLOGICAL: Engerix™-B

Sponsor

GlaxoSmithKline